Propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillation

Aim. To study the effects of three-month propafenone antiarrhythmic therapy (daily dose 450 mg) on inotropic myocardial function in patients with recurrent atrial fibrillation (AF). Material and methods. The study included 18 (100%) patients aged 39-59 years (mean age 51.7±6.7 years), receiving prop...

Full description

Saved in:
Bibliographic Details
Main Authors: I. G. Fomina, A. I. Tarzimanova, A. V. Vetluzhsky
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2006-06-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1199
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849342018282586112
author I. G. Fomina
A. I. Tarzimanova
A. V. Vetluzhsky
author_facet I. G. Fomina
A. I. Tarzimanova
A. V. Vetluzhsky
author_sort I. G. Fomina
collection DOAJ
description Aim. To study the effects of three-month propafenone antiarrhythmic therapy (daily dose 450 mg) on inotropic myocardial function in patients with recurrent atrial fibrillation (AF). Material and methods. The study included 18 (100%) patients aged 39-59 years (mean age 51.7±6.7 years), receiving propafenone (450 mg/d) for 3 months, to prevent recurrent AF. To assess antiarrhythmic therapy effects on inotropic myocardial function, all participants underwent balanced radionuclide ventriculography at baseline; in patients with maintained sinus rhythm, it was repeated after 3 months of treatment. Results. In first 3 days after restoring sinus rhythm in recurrent AF patients, diastolic function dynamics was observed: significant reduction in 1/3 diastole filling and peak filling velocity. After 3 months of propafenone treatment, left ventricular (LF) 1/3 diastole filling (p<0.05), as well as LV and right ventricular (RV) filling peak velocity (p<0.05), significantly increased. Ejection fraction, systolic and volumic parameters of LV and RV stayed within the normal range and did not change significantly. After 3-month propafenone therapy, recurrent AF patients demonstrated significant increase in atrial input into LV diastole – from 17.1±5.7% to 22.1±6.5%, and RV diastole – from 17.3±5.1% to 21.1±6.2% (р<0.05). Conclusion. Propafenone therapy (450 mg/d) facilitated 3-month sinus rhythm maintenance in 77% patients with recurrent AF. The therapy did not affect LF and RV inotropic myocardial function. Maintaining sinus rhythm for 3 moths facilitated normalization of atrial contractility and ventricular diastolic dysfunction improvement.
format Article
id doaj-art-e9d632d0fac54459b1ded7564d320253
institution Kabale University
issn 1728-8800
2619-0125
language Russian
publishDate 2006-06-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-e9d632d0fac54459b1ded7564d3202532025-08-20T03:43:30Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252006-06-01534954911Propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillationI. G. Fomina0A. I. Tarzimanova1A. V. Vetluzhsky2I.M. Sechenov Moscow Medical Academy, City Clinical Hospital No. 61. MoscowI.M. Sechenov Moscow Medical Academy, City Clinical Hospital No. 61. MoscowI.M. Sechenov Moscow Medical Academy, City Clinical Hospital No. 61. MoscowAim. To study the effects of three-month propafenone antiarrhythmic therapy (daily dose 450 mg) on inotropic myocardial function in patients with recurrent atrial fibrillation (AF). Material and methods. The study included 18 (100%) patients aged 39-59 years (mean age 51.7±6.7 years), receiving propafenone (450 mg/d) for 3 months, to prevent recurrent AF. To assess antiarrhythmic therapy effects on inotropic myocardial function, all participants underwent balanced radionuclide ventriculography at baseline; in patients with maintained sinus rhythm, it was repeated after 3 months of treatment. Results. In first 3 days after restoring sinus rhythm in recurrent AF patients, diastolic function dynamics was observed: significant reduction in 1/3 diastole filling and peak filling velocity. After 3 months of propafenone treatment, left ventricular (LF) 1/3 diastole filling (p<0.05), as well as LV and right ventricular (RV) filling peak velocity (p<0.05), significantly increased. Ejection fraction, systolic and volumic parameters of LV and RV stayed within the normal range and did not change significantly. After 3-month propafenone therapy, recurrent AF patients demonstrated significant increase in atrial input into LV diastole – from 17.1±5.7% to 22.1±6.5%, and RV diastole – from 17.3±5.1% to 21.1±6.2% (р<0.05). Conclusion. Propafenone therapy (450 mg/d) facilitated 3-month sinus rhythm maintenance in 77% patients with recurrent AF. The therapy did not affect LF and RV inotropic myocardial function. Maintaining sinus rhythm for 3 moths facilitated normalization of atrial contractility and ventricular diastolic dysfunction improvement.https://cardiovascular.elpub.ru/jour/article/view/1199atrial fibrillationpropafenoneheart inotropic functionatrial remodeling
spellingShingle I. G. Fomina
A. I. Tarzimanova
A. V. Vetluzhsky
Propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillation
Кардиоваскулярная терапия и профилактика
atrial fibrillation
propafenone
heart inotropic function
atrial remodeling
title Propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillation
title_full Propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillation
title_fullStr Propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillation
title_full_unstemmed Propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillation
title_short Propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillation
title_sort propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillation
topic atrial fibrillation
propafenone
heart inotropic function
atrial remodeling
url https://cardiovascular.elpub.ru/jour/article/view/1199
work_keys_str_mv AT igfomina propafenoneeffectoninotropicmyocardialfunctioninpatientswithrecurrentatralfibrillation
AT aitarzimanova propafenoneeffectoninotropicmyocardialfunctioninpatientswithrecurrentatralfibrillation
AT avvetluzhsky propafenoneeffectoninotropicmyocardialfunctioninpatientswithrecurrentatralfibrillation